GB9008850D0
(en)
*
|
1990-04-19 |
1990-06-13 |
Janssen Pharmaceutica Nv |
Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
|
AU672182B2
(en)
*
|
1991-11-27 |
1996-09-26 |
Novo Nordisk A/S |
Piperidine derivatives and their use in treating psychosis
|
US5378714A
(en)
*
|
1991-11-27 |
1995-01-03 |
Novo Nordisk A/S |
Antipsychotic piperidine derivatives
|
ES2050069B1
(es)
*
|
1992-07-10 |
1994-12-16 |
Vita Invest Sa |
Procedimiento para la obtencion de 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-il)piperidino)etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido(1,2-a) pirimidin-4-ona.
|
DK60793D0
(da)
*
|
1993-05-26 |
1993-05-26 |
Novo Nordisk As |
Kemiske forbindelser, deres fremstilling og anvendelse
|
DK60593D0
(da)
*
|
1993-05-26 |
1993-05-26 |
Novo Nordisk As |
Kemiske forbindelser, deres fremstilling og anvendelse
|
JP3645906B2
(ja)
*
|
1993-11-19 |
2005-05-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
マイクロカプセル封入された3−ピペリジニル−置換1,2−ベンズイソオキサゾール類及び1,2−ベンズイソチアゾール類
|
RU2126406C1
(ru)
*
|
1993-11-23 |
1999-02-20 |
Жансен Фармасетика Н.В. |
Эфирные производные 9-гидрокси-пиридо[1,2-а]пиримидин-4-она, способ их получения, композиция, обладающая антипсихотической активностью и способ ее получения
|
ES2085234B1
(es)
*
|
1994-02-24 |
1997-01-16 |
Vita Invest Sa |
Agente activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
|
TW487572B
(en)
*
|
1996-05-20 |
2002-05-21 |
Janssen Pharmaceutica Nv |
Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
|
US6028083A
(en)
*
|
1997-07-25 |
2000-02-22 |
Hoechst Marion Roussel, Inc. |
Esters of (+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol
|
UA72189C2
(uk)
*
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
ES2141671B1
(es)
*
|
1997-12-26 |
2001-01-01 |
Vita Invest Sa |
Compuesto pirimidinico activo sobre el sistema nervioso central, procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
|
WO1999059589A1
(fr)
*
|
1998-05-18 |
1999-11-25 |
Sepracor Inc. |
Compositions d'hydroxyrisperidone (-) et methodes associees
|
AU3900499A
(en)
*
|
1998-05-18 |
1999-12-06 |
Sepracor, Inc. |
(+)-hydroxyrisperidone compositions and methods
|
AU5489299A
(en)
|
1998-08-18 |
2000-03-14 |
Sepracor, Inc. |
Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
|
ES2197801B1
(es)
*
|
2002-03-05 |
2005-03-16 |
Ferrer Internacional,S.A |
Procedimiento de obtencion de la 3-(2-(4-(6-fluoro-benzo(d)isoxazol-3-il) piperidin-1-il)-etil)-2-metil-6,7,8,9-tetrahidro-4h-pirido-(1,2-a ) pirimidin-4-ona.
|
KR20040025224A
(ko)
*
|
2002-09-18 |
2004-03-24 |
주식회사 대웅 |
2-(2-메틸-4-옥소-6,7,8,9-테트라하이드로-4H-피리도[1,2-a]피리미딘-3-일)아세트알데히드 및 그 제조방법
|
AU2003288017A1
(en)
|
2002-11-13 |
2004-06-03 |
Synthon B.V. |
Process for making risperidone and intermediates therefor
|
ES2546268T3
(es)
|
2004-09-09 |
2015-09-22 |
Janssen Pharmaceutica Nv |
Preparación de 9-hidroxi-3-(2-hidroxietil)-2-metil-4H-pirido[1,2-a]pirimidin-4-ona y sus cristales
|
US20070197591A1
(en)
|
2005-12-12 |
2007-08-23 |
Sandra Boom |
Use of paliperidone for the treatment of a mental disorder in a psychiatric patient with reduced hepatic function
|
EP2133352A3
(fr)
*
|
2006-08-14 |
2010-01-13 |
Teva Pharmaceutical Industries Ltd. |
Forme cristalline de la 9-hydroxy-rispéridone (palipéridone)
|
WO2008021342A2
(fr)
*
|
2006-08-14 |
2008-02-21 |
Teva Pharmaceutical Industries Ltd. |
Formes cristallines de la 9-hydroxy-rispéridone (palipéridone)
|
EP2133351A3
(fr)
*
|
2006-08-14 |
2010-01-13 |
Teva Pharmaceutical Industries Ltd. |
Forme cristalline de la 9-hydroxy-rispéridone (palipéridone)
|
US7820816B2
(en)
|
2006-08-23 |
2010-10-26 |
Teva Pharmaceutical Industries Ltd. |
Process for the synthesis of CMHTP and intermediates thereof
|
KR20090079189A
(ko)
*
|
2006-08-23 |
2009-07-21 |
테바 파마슈티컬 인더스트리즈 리미티드 |
Cmhtp 및 이의 중간체의 합성 방법
|
US8071767B2
(en)
|
2007-01-08 |
2011-12-06 |
Actavis Group Ptc Ehf |
Process for preparation of 9-hydroxy-3-(2-chloroethyl)-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one hydrochloride
|
US8314110B2
(en)
*
|
2007-04-19 |
2012-11-20 |
Youxin Li |
Compounds for treating mental disorders, and preparation and uses thereof
|
WO2009010988A1
(fr)
*
|
2007-07-19 |
2009-01-22 |
Natco Pharma Limited |
Procédé amélioré, industriellement viable pour la préparation de palipéridone de haute pureté
|
EP2178872A1
(fr)
*
|
2007-07-27 |
2010-04-28 |
Synthon B.V. |
Dérivés de palipéridone
|
WO2009045489A2
(fr)
*
|
2007-10-03 |
2009-04-09 |
Teva Pharmaceutical Industries Ltd. |
Procédé de synthèse de cmhtp, un intermédiaire de la palipéridone
|
AU2008309411B2
(en)
*
|
2007-10-09 |
2013-01-31 |
Cipla Limited |
Processes for the preparation of paliperidone and pharmaceutically acceptable salts thereof and intermediates for use in the processes
|
WO2009074333A1
(fr)
*
|
2007-12-10 |
2009-06-18 |
Synthon B.V. |
Synthèse de palipéridone
|
NZ586930A
(en)
*
|
2008-02-05 |
2012-06-29 |
Watson Pharma Private Ltd |
An improved process for preparation of paliperidone
|
US20110087024A1
(en)
*
|
2008-04-21 |
2011-04-14 |
Glenmark House |
process for the preparation of paliperidone intermediates
|
EP2303877B1
(fr)
|
2008-05-29 |
2017-02-15 |
Inke, S.A. |
Procédé de fabrication de la palipéridone et d'intermédiaires pour celui-ci
|
WO2010004578A2
(fr)
*
|
2008-06-16 |
2010-01-14 |
Msn Laboratories Limited |
Nouveaux procédés améliorés de préparation de la palipéridone
|
WO2010003702A1
(fr)
*
|
2008-07-11 |
2010-01-14 |
Synthon B.V. |
Synthèse de palipéridone
|
US7932385B2
(en)
|
2008-07-11 |
2011-04-26 |
Synthon Bv |
Paliperidone ketone
|
SI22856A
(sl)
*
|
2008-07-31 |
2010-02-26 |
Krka, Tovarna Zdravil, D.D., Novo Mesto |
Proces za pripravo paliperidona
|
EP2161019A1
(fr)
|
2008-09-05 |
2010-03-10 |
KRKA, D.D., Novo Mesto |
Composition pharmaceutique multi-particules à libération prolongée comportant de la palipéridone
|
EP2199293A1
(fr)
|
2008-12-22 |
2010-06-23 |
Chemo Ibérica, S.A. |
Procédé à étape unique pour la préparation de palipéridone en son sel d'oxalate
|
EP2202234A1
(fr)
|
2008-12-24 |
2010-06-30 |
Laboratorios Lesvi, S.L. |
Purification de la palipéridone
|
ATE544766T1
(de)
|
2009-07-13 |
2012-02-15 |
Krka |
Verfahren zur synthese von paliperidon
|
WO2011018246A2
(fr)
|
2009-08-13 |
2011-02-17 |
Synthon B.V. |
Composition de palipéridone à libération contrôlée
|
EP2343296A1
(fr)
|
2009-12-01 |
2011-07-13 |
Chemo Ibérica, S.A. |
Procédé pour la purification de la palipéridone
|
WO2011074017A1
(fr)
*
|
2009-12-17 |
2011-06-23 |
Alkem Laboratories Ltd. |
Nouveau procédé de préparation de palipéridone
|
US8088594B2
(en)
*
|
2010-03-16 |
2012-01-03 |
Saladax Biomedical Inc. |
Risperidone immunoassay
|
WO2012035554A1
(fr)
*
|
2010-09-14 |
2012-03-22 |
Megafine Pharma (P) Ltd. |
Procédé amélioré de préparation de palipéridone très pure
|
MX346185B
(es)
|
2010-11-15 |
2017-03-10 |
Agenebio Inc |
Derivados de piridazina, composiciones y metodos para tratar deterioro cognitivo.
|
CN102153552B
(zh)
*
|
2011-03-01 |
2012-08-22 |
吉林大学 |
两种帕潘立酮药物共晶及其制备方法
|
CN102206210B
(zh)
*
|
2011-04-01 |
2014-07-02 |
常州市第四制药厂有限公司 |
一种6-氟-3-(4-哌啶基)-1,2-苯并异噁唑盐酸盐的生产方法
|
EP2919788A4
(fr)
|
2012-11-14 |
2016-05-25 |
Univ Johns Hopkins |
Méthodes et compositions pour le traitement de la schizophrénie
|
US10329301B2
(en)
|
2013-12-20 |
2019-06-25 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US10815242B2
(en)
|
2015-06-19 |
2020-10-27 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US11505555B2
(en)
|
2016-12-19 |
2022-11-22 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US20180170941A1
(en)
|
2016-12-19 |
2018-06-21 |
Agenebio, Inc. |
Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
|
US11377445B2
(en)
|
2018-02-21 |
2022-07-05 |
Zenvision Pharma Llp |
Derivatives of paliperidone and process for the preparation thereof
|
WO2019246300A1
(fr)
|
2018-06-19 |
2019-12-26 |
Agenebio, Inc. |
Dérivés de benzodiazépine, compositions, et méthodes de traitement de déficience cognitive
|
US20240132513A1
(en)
|
2022-08-19 |
2024-04-25 |
Agenebio, Inc. |
Benzazepine derivatives, compositions, and methods for treating cognitive impairment
|
CN116003404A
(zh)
*
|
2022-12-14 |
2023-04-25 |
杭州同舟生物技术有限公司 |
一种利培酮人工半抗原、人工抗原及其制备方法和应用
|